The economic burden of cancer in Korea in 2009
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, S.Y. | - |
dc.contributor.author | Park, J.-H. | - |
dc.contributor.author | Kang, K.H. | - |
dc.contributor.author | Hwang, I. | - |
dc.contributor.author | Yang, H.K. | - |
dc.contributor.author | Won, Y.-J. | - |
dc.contributor.author | Seo, H.-G. | - |
dc.contributor.author | Lee, D. | - |
dc.contributor.author | Yoon, S.-J. | - |
dc.date.accessioned | 2021-09-05T00:01:15Z | - |
dc.date.available | 2021-09-05T00:01:15Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2015 | - |
dc.identifier.issn | 1513-7368 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/95955 | - |
dc.description.abstract | Background: Cancer imposes a significant economic burden on individuals, families and society. The purpose of this study was to estimate the economic burden of cancer using the healthcare claims and cancer registry data in Korea in 2009. Materials and Methods: The economic burden of cancer was estimated using the prevalence data where patients were identified in the Korean Central Cancer Registry. We estimated the medical, non-medical, morbidity and mortality cost due to lost productivity. Medical costs were calculated using the healthcare claims data obtained from the Korean National Health Insurance (KNHI) Corporation. Non-medical costs included the cost of transportation to visit health providers, costs associated with caregiving for cancer patients, and costs for complementary and alternative medicine (CAM). Data acquired from the Korean National Statistics Office and Ministry of Labor were used to calculate the life expectancy at the time of death, age- and gender-specific wages on average, adjusted for unemployment and labor force participation rate. Sensitivity analysis was performed to derive the current value of foregone future earnings due to premature death, discounted at 3% and 5%. Results: In 2009, estimated total economic cost of cancer amounted to $17.3 billion at a 3% discount rate. Medical care accounted for 28.3% of total costs, followed by non-medical (17.2%), morbidity (24.2%) and mortality (30.3%) costs. Conclusions: Given that the direct medical cost sharply increased over the last decade, we must strive to construct a sustainable health care system that provides better care while lowering the cost. In addition, a comprehensive cancer survivorship policy aimed at lower caregiving cost and higher rate of return to work has become more important than previously considered. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | Asian Pacific Organization for Cancer Prevention | - |
dc.subject | adolescent | - |
dc.subject | adult | - |
dc.subject | aged | - |
dc.subject | cancer staging | - |
dc.subject | cost of illness | - |
dc.subject | economics | - |
dc.subject | female | - |
dc.subject | follow up | - |
dc.subject | health care cost | - |
dc.subject | human | - |
dc.subject | life expectancy | - |
dc.subject | male | - |
dc.subject | middle aged | - |
dc.subject | Neoplasms | - |
dc.subject | prevalence | - |
dc.subject | prognosis | - |
dc.subject | public health | - |
dc.subject | South Korea | - |
dc.subject | statistics and numerical data | - |
dc.subject | time | - |
dc.subject | young adult | - |
dc.subject | Adolescent | - |
dc.subject | Adult | - |
dc.subject | Aged | - |
dc.subject | Cost of Illness | - |
dc.subject | Female | - |
dc.subject | Follow-Up Studies | - |
dc.subject | Health Care Costs | - |
dc.subject | Humans | - |
dc.subject | Life Expectancy | - |
dc.subject | Male | - |
dc.subject | Middle Aged | - |
dc.subject | National Health Programs | - |
dc.subject | Neoplasm Staging | - |
dc.subject | Neoplasms | - |
dc.subject | Prevalence | - |
dc.subject | Prognosis | - |
dc.subject | Republic of Korea | - |
dc.subject | Time Factors | - |
dc.subject | Young Adult | - |
dc.title | The economic burden of cancer in Korea in 2009 | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Yoon, S.-J. | - |
dc.identifier.doi | 10.7314/APJCP.2015.16.3.1295 | - |
dc.identifier.scopusid | 2-s2.0-84929319138 | - |
dc.identifier.bibliographicCitation | Asian Pacific Journal of Cancer Prevention, v.16, no.3, pp.1295 - 1301 | - |
dc.relation.isPartOf | Asian Pacific Journal of Cancer Prevention | - |
dc.citation.title | Asian Pacific Journal of Cancer Prevention | - |
dc.citation.volume | 16 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 1295 | - |
dc.citation.endPage | 1301 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.subject.keywordPlus | adolescent | - |
dc.subject.keywordPlus | adult | - |
dc.subject.keywordPlus | aged | - |
dc.subject.keywordPlus | cancer staging | - |
dc.subject.keywordPlus | cost of illness | - |
dc.subject.keywordPlus | economics | - |
dc.subject.keywordPlus | female | - |
dc.subject.keywordPlus | follow up | - |
dc.subject.keywordPlus | health care cost | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | life expectancy | - |
dc.subject.keywordPlus | male | - |
dc.subject.keywordPlus | middle aged | - |
dc.subject.keywordPlus | Neoplasms | - |
dc.subject.keywordPlus | prevalence | - |
dc.subject.keywordPlus | prognosis | - |
dc.subject.keywordPlus | public health | - |
dc.subject.keywordPlus | South Korea | - |
dc.subject.keywordPlus | statistics and numerical data | - |
dc.subject.keywordPlus | time | - |
dc.subject.keywordPlus | young adult | - |
dc.subject.keywordPlus | Adolescent | - |
dc.subject.keywordPlus | Adult | - |
dc.subject.keywordPlus | Aged | - |
dc.subject.keywordPlus | Cost of Illness | - |
dc.subject.keywordPlus | Female | - |
dc.subject.keywordPlus | Follow-Up Studies | - |
dc.subject.keywordPlus | Health Care Costs | - |
dc.subject.keywordPlus | Humans | - |
dc.subject.keywordPlus | Life Expectancy | - |
dc.subject.keywordPlus | Male | - |
dc.subject.keywordPlus | Middle Aged | - |
dc.subject.keywordPlus | National Health Programs | - |
dc.subject.keywordPlus | Neoplasm Staging | - |
dc.subject.keywordPlus | Neoplasms | - |
dc.subject.keywordPlus | Prevalence | - |
dc.subject.keywordPlus | Prognosis | - |
dc.subject.keywordPlus | Republic of Korea | - |
dc.subject.keywordPlus | Time Factors | - |
dc.subject.keywordPlus | Young Adult | - |
dc.subject.keywordAuthor | Cancer | - |
dc.subject.keywordAuthor | Cost analysis | - |
dc.subject.keywordAuthor | Cost of illness | - |
dc.subject.keywordAuthor | Health care costs | - |
dc.subject.keywordAuthor | Korea | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.